Higher cost of implementing Xpert MTB/RIF in Ugandan peripheral settings: Implications for cost-effectiveness

SETTING: Initial cost-effectiveness evaluations of Xpert MTB/RIF (Xpert) for tuberculosis (TB) diagnosis have not fully accounted for realities of implementation in peripheral settings. OBJECTIVE: We evaluated costs and diagnostic outcomes of Xpert testing implemented at various healthcare levels in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Tuberc Lung Dis
Egile Nagusiak: Hsiang, Esther, Little, Kristen M, Haguma, Priscilla, Hanrahan, Colleen F, Katamba, Achilles, Cattamanchi, Adithya, Davis, J Lucian, Vassall, Anna, Dowdy, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5018405/
https://ncbi.nlm.nih.gov/pubmed/27510248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.16.0200
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak